September 23, 2026
1 min read

Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks

Despite hitting a speed bump over the summer, automated cell therapy manufacturing specialist Cellares has continued to sign new partners at a steady pace, now inking a second agreement with an Asia-based organization in just over a week.

Leave a Reply

Your email address will not be published.

Previous Story

Kids’ Vaccinations Don’t Have To Be Scary Or Painful, New Guidelines Argue MedNews

Next Story

The latest in the legal saga for youth gender-affirming care in the U.S.

Previous Story

Kids’ Vaccinations Don’t Have To Be Scary Or Painful, New Guidelines Argue MedNews

Next Story

The latest in the legal saga for youth gender-affirming care in the U.S.

Latest from Blog

Go toTop